Editorial notes
-
ULSS1 Dolomites. ISF access. Ed
Access is only possible for those who have undergone a swab, with negative results, in the last 48 hours. From…
Leggi » -
ULSS5 Polesana announces the methods of access for product specialists. Ed
The ULSS5 Polesana informs that the access of Product Specialists and Consultants to the operating groups is subject to a…
Leggi » -
AstraZeneca. Digital channels added value for the profession of scientific medical informant. Ed
An AstraZeneca editorial has been published on AboutPharma which analyzes the transformation of the NHS in the era of a pandemic and the…
Leggi » -
Fidia's scientific representatives choose USB. Ed
At the Fidia Farmaceutici headquarters, the procedures for electing the new RSU were completed. The Operational Forces sector…
Leggi » -
Who finances the Italian Medicines Agency (Aifa). Ed
Professor Silvio Garattini, 90, founder of the Mario Negri Institute, has long argued that "half of the drugs are useless,…
Leggi » -
Cagliari, a couple of medical-scientific informants reported for fraud by an "irregular" company. Ed
They defrauded a pharmaceutical company in the Brianza area: a couple of informants from Cagliari were reported They had devised an ingenious system to charge commissions…
Leggi » -
Garattini: "For the consumption of medicines independent information, prohibit the ISF access to clinics and hospitals" Editor's note
"For the consumption of medicines independent information". The article appeared in l'Eco di Bergamo – 17 August 2020. We report extensive…
Leggi » -
Cosenza. Fedaiisf and ISF Masons. Delusional and defamatory accusations. Ed
On the newspaper "Iacchitè" of July 4 (and also reported on Facebook) a letter was published from a non better ...
Leggi » -
Siena. ISF access to hospital according to guidelines
Ordinance 60 of 27 May 2020 - Containment and management of the epidemiological emergency from COVID-19. Further measures for…
Leggi » -
Financial Times research on diversity as a value in the company. I asked for 68th.
Financial Times conducted with the German research partner “Statista”, a research to evaluate the success of companies in…
Leggi »